In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
All content for Genetic Sounds is the property of The European Society of Human Genetics and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
E1 - Harnessing African Genetic Population for Global Health
Genetic Sounds
41 minutes
2 years ago
E1 - Harnessing African Genetic Population for Global Health
As we return with our second series of Genetic Sounds, in this first episode we discuss the background of the African Society of Human Genetics, and Equity in African research. A conversation with Professor Ambroise Wonkam, President of the African Society of Human Genetics, Human Genetics Scientist Professor Michele Ramsay, based at the University of Witswatersrand, Johannesburg, Dr Rokhaya Ndiaye, from the Senegal Human Genetics Society, and Dr Vicky Nembaware, current secretory for the Afr...
Genetic Sounds
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
